| For: | Ioannidis I. Diabetes treatment in patients with renal disease: Is the landscape clear enough? World J Diabetes 2014; 5(5): 651-658 [PMID: 25317242 DOI: 10.4239/wjd.v5.i5.651] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v5/i5/651.htm |
| Number | Citing Articles |
| 1 |
T.A. Sonia, Chandra P. Sharma. Oral Delivery of Insulin. 2026; doi: 10.1016/B978-0-443-30272-5.00007-X
|
| 2 |
George Bonifant, Stephen N Davis, Matthew R Weir. Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure. Nephrology Dialysis Transplantation 2025; 41(1) doi: 10.1093/ndt/gfaf083
|
| 3 |
Cheli Melzer-Cohen, Avraham Karasik, Philipp J. Leuschner, Joseph Azuri, Varda Shalev, Gabriel Chodick. Dose adjustment of metformin and dipeptidyl-peptidase IV inhibitors in diabetic patients with renal dysfunction. Current Medical Research and Opinion 2018; 34(10) doi: 10.1080/03007995.2018.1459529
|
| 4 |
Miroslava Nedyalkova, Sergio Madurga, Davide Ballabio, Ralitsa Robeva, Julia Romanova, Ilia Kichev, Atanaska Elenkova, Vasil Simeonov. Diabetes mellitus type 2: Exploratory data analysis based on clinical reading. Open Chemistry 2020; 18(1) doi: 10.1515/chem-2020-0086
|
| 5 |
Himanshu Naik, Richard Czerniak, Majid Vakilynejad. Application of pharmacometric approaches to evaluate effect of weight and renal function on pharmacokinetics of alogliptin. British Journal of Clinical Pharmacology 2016; 81(4) doi: 10.1111/bcp.12853
|
| 6 |
S. Seidu, X. Cos, S. Brunton, S.B. Harris, S.P.O. Jansson, M. Mata-Cases, A.M.J. Neijens, P. Topsever, K. Khunti. A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe. Primary Care Diabetes 2021; 15(1) doi: 10.1016/j.pcd.2020.05.004
|
| 7 |
Yu. S. Gavrilova, N. P. Bgatova, V. V. Klimontov, I. Yu. Ischenko, S. V. Michurina, N. E. Myakina, E. L. Zavyalov. Effect of Linagliptin on Structural Changes in the Kidney in Experimental Type 2 Diabetes Mellitus. Bulletin of Experimental Biology and Medicine 2016; 161(4) doi: 10.1007/s10517-016-3447-6
|
| 8 |
Stephen Colagiuri, David Matthews, Lawrence A. Leiter, Siew Pheng Chan, Giorgio Sesti, Michel Marre. The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents. Diabetes Research and Clinical Practice 2018; 143 doi: 10.1016/j.diabres.2018.05.028
|
| 9 |
Sumaira Tasleem, Farogh Ahsan, Shahzadi Bano, Tarique Mahmood, Asad Ahmad, Soheir A. A. Hagras, Mohammad Sarafroz, Syed Mehdi Hasan Zaidi, Divyanshi Saxena. Nephroprotective Potential of Linagliptin and Glimepiride: a Comprehensive Review. Current Pharmacology Reports 2026; 12(1) doi: 10.1007/s40495-026-00456-z
|
| 10 |
Samantha T. Harris, Elisabetta Patorno, Min Zhuo, Seoyoung C. Kim, Julie M. Paik. Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Cohort Study. Diabetes Care 2021; 44(10) doi: 10.2337/dc21-0529
|
| 11 |
E Lioudaki, M Whyte, ES Androulakis, KG Stylianou, EK Daphnis, ES Ganotakis. Renal Effects of SGLT‐2 Inhibitors and Other Anti‐diabetic Drugs: Clinical Relevance and Potential Risks. Clinical Pharmacology & Therapeutics 2017; 102(3) doi: 10.1002/cpt.731
|
| 12 |
Ashok K. Das, Subhash K. Wangnoo, Rajeev Chawla, Altamash Shaikh, Ganapathi Bantwal, Pramila Kalra, Shalini Jaggi, Mahesh V. Abhyankar, Ashish Prasad, Prashant Sarda. Expert Consensus on Triple Combination of Glimepiride, Metformin, and Voglibose Usage in Patients with Type 2 Diabetes Mellitus in Indian Settings. Journal of Diabetology 2022; 13(2) doi: 10.4103/jod.jod_118_21
|
| 13 |
Min Zhang, Yan Zhang, Che Li, Linhua He. Association between red blood cell distribution and renal function in patients with untreated type 2 diabetes mellitus. Renal Failure 2015; 37(4) doi: 10.3109/0886022X.2015.1010938
|
| 14 |
Lee-Ann Wagner, Jeffrey C. Fink. Ensuring Patient Safety During the Transition to ESRD. Seminars in Nephrology 2017; 37(2) doi: 10.1016/j.semnephrol.2016.12.009
|
| 15 |
Jianwen Wang, Jie Huang, Wei Li, Shiqi Tang, Jian Sun, Xianming Zhang, Jun Liu, Bin Yi, Jishi Liu, Xingfei Zhang, Qian Yang, Xiaoyan Yang, Shuang Yang, Guoping Yang, Hao Zhang. Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic study. British Journal of Clinical Pharmacology 2019; 85(12) doi: 10.1111/bcp.14091
|
| 16 |
Rajan Goyal, Himanshu Jindal, Abhilasha Singh, Abhishek Kamendu. Evaluation of Pattern of Use of Prescribed Oral Hypoglycaemic Drugs in Newly Diagnosed Diabetic Nephropathy Patients Visiting a Tertiary Care Hospital of Southern Bihar. Journal of Evidence Based Medicine and Healthcare 2020; 7(43) doi: 10.18410/jebmh/2020/515
|
| 17 |
Mohamed Hassanein, Mousa A. J. Akbar, Mostafa Al-shamiri, Ashraf Amir, Aslam Amod, Richard Chudleigh, Tarik Elhadd, Hussien Heshmat, Mahdi Jibani, Yousef M. Al Saleh. Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies. Diabetes Therapy 2022; 13(7) doi: 10.1007/s13300-022-01282-4
|
| 18 |
Carles Zafon. New therapeutic approaches in type 2 diabetes mellitus. Medicina Clínica (English Edition) 2015; 145(11) doi: 10.1016/j.medcle.2016.04.005
|
| 19 |
Alyson Myers, Patricia Garnica, Jason Ling. Advances in Managing Type 2 Diabetes in the Elderly: A Focus on Inpatient Care and Transitions of Care. American Journal of Therapeutics 2018; 25(1) doi: 10.1097/MJT.0000000000000667
|
| 20 |
Amir Khan. Impact of race-based calculations of eGFR on the management of muscle invasive bladder cancer. American Journal of Clinical and Experimental Urology 2024; 12(6) doi: 10.62347/DOCH1460
|
| 21 |
Sarita Bajaj, BrijMohan Makkar, VinodK Abichandani, PradeepG Talwalkar, Banshi Saboo, SS Srikanta, Ashok Das, Sruti Chandrasekaran, PVenkata Krishnan, Arun Shah, Georgi Abraham, Pankaj Tikku, Sushil Kumar. Management of anemia in patients with diabetic kidney disease: A consensus statement. Indian Journal of Endocrinology and Metabolism 2016; 20(2) doi: 10.4103/2230-8210.176348
|
| 22 |
Andrés Carmona, Maria L. Agüera, Carlos Luna-Ruiz, Paula Buendía, Laura Calleros, Andrea García-Jerez, Manuel Rodríguez-Puyol, Manuel Arias, Marta Arias-Guillen, Gabriel de Arriba, Jose Ballarin, Carmen Bernis, Elvira Fernández, Sagrario García-Rebollo, Javier Mancha, Gloria del Peso, Estefanía Pérez, Esteban Poch, Jose M. Portolés, Diego Rodríguez-Puyol, Rafael Sánchez-Villanueva, Felipe Sarro, Armando Torres, Alejandro Martín-Malo, Pedro Aljama, Rafael Ramírez, Julia Carracedo. Markers of endothelial damage in patients with chronic kidney disease on hemodialysis. American Journal of Physiology-Renal Physiology 2017; 312(4) doi: 10.1152/ajprenal.00013.2016
|
| 23 |
Rajeev Chawla, S. V. Madhu, B. M. Makkar, Sujoy Ghosh, Banshi Saboo, Sanjay Kalra. RSSDI-ESI Clinical Practice Recommendations for the Management
of Type 2 Diabetes Mellitus 2020. International Journal of Diabetes in Developing Countries 2020; 40(S1) doi: 10.1007/s13410-020-00819-2
|
| 24 |
Subhash Wangnoo, M. Shunmugavelu, Sagili Vijaya Bhaskar Reddy, Vijay Negalur, Shreerang Godbole, Vinay K Dhandhania, Nareen Krishna, Kumar Gaurav. Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India. Endocrine and Metabolic Science 2021; 4 doi: 10.1016/j.endmts.2021.100102
|
| 25 |
Ada Offurum, Lee-Ann Wagner, Tanisha Gooden. Adverse safety events in patients with Chronic Kidney Disease (CKD). Expert Opinion on Drug Safety 2016; 15(12) doi: 10.1080/14740338.2016.1236909
|
| 26 |
|
| 27 |
Michael Zeisberg, Elisabeth M. Zeisberg. Evidence for antifibrotic incretin-independent effects of the DPP-4 inhibitor linagliptin. Kidney International 2015; 88(3) doi: 10.1038/ki.2015.175
|
| 28 |
S. Seidu, X. Cos, S. Brunton, S.B. Harris, S.P.O. Jansson, M. Mata-Cases, A.M.J. Neijens, P. Topsever, K. Khunti. 2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care. Primary Care Diabetes 2022; 16(2) doi: 10.1016/j.pcd.2022.02.002
|
| 29 |
Fernanda Guilhermino Magalhães, Rita Maria Monteiro Goulart. Doença renal crônica e tratamento em idosos: uma revisão integrativa. Revista Brasileira de Geriatria e Gerontologia 2015; 18(3) doi: 10.1590/1809-9823.2015.14132
|
| 30 |
Dragana Lovre, Sulay Shah, Aanu Sihota, Vivian A. Fonseca. Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients. Endocrinology and Metabolism Clinics of North America 2018; 47(1) doi: 10.1016/j.ecl.2017.10.006
|
| 31 |
Freddy G. Eliaschewitz, Luis Henrique Canani. Advances in GLP-1 treatment: focus on oral semaglutide. Diabetology & Metabolic Syndrome 2021; 13(1) doi: 10.1186/s13098-021-00713-9
|
| 32 |
Elmukhtar Habas, Mehdi Errayes, Eshrak Habas, Khalifa L Farfar, Gamal Alfitori, Ala E Habas, Amnna Rayani, Abdel-Naser Y Elzouki. Fasting Ramadan in Chronic Kidney Disease (CKD), Kidney Transplant and Dialysis Patients: Review and Update. Cureus 2022; doi: 10.7759/cureus.25269
|
| 33 |
Carles Zafon. Nuevos planteamientos terapéuticos en la diabetes mellitus tipo 2. Medicina Clínica 2015; 145(11) doi: 10.1016/j.medcli.2015.05.008
|
| 34 |
Rajeev Chawla, SV Madhu, BM Makkar, Sujoy Ghosh, Banshi Saboo, Sanjay Kalra. RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. Indian Journal of Endocrinology and Metabolism 2020; 24(1) doi: 10.4103/ijem.IJEM_225_20
|
| 35 |
Chia-Wei Chang, Ya-Wen Sung, Yu-Ting Huang, Yong-Chuan Chung, Mei-Yueh Lee. Better Detection of Peripheral Arterial Disease with Toe-Brachial Index Compared to Ankle-Brachial Index among Taiwanese Patients with Diabetic Kidney Disease. Journal of Clinical Medicine 2023; 12(23) doi: 10.3390/jcm12237393
|
| 36 |
Lies Moonen, Patrick C. D’Haese, Benjamin A. Vervaet. Epithelial Cell Cycle Behaviour in the Injured Kidney. International Journal of Molecular Sciences 2018; 19(7) doi: 10.3390/ijms19072038
|
| 37 |
Dionysis Spanopoulos, Hajra Okhai, Francesco Zaccardi, Abigail Tebboth, Brendan Barrett, Michael Busse, Joanne Webb, Kamlesh Khunti. Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study. Diabetes, Obesity and Metabolism 2019; 21(8) doi: 10.1111/dom.13734
|
| 38 |
Danny Meetoo, Sabah Alsomali. NG28: Promoting patient-centred care for adults with type 2 diabetes. Nurse Prescribing 2016; 14(5) doi: 10.12968/npre.2016.14.5.236
|
| 39 |
Viswanathan Mohan, Mark E. Cooper, David R. Matthews, Kamlesh Khunti. The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm. Diabetes Therapy 2019; 10(S1) doi: 10.1007/s13300-019-0573-y
|
| 40 |
Sanjay Kalra, Silver Bahendeka, Rakesh Sahay, Sujoy Ghosh, Fariduddin Md, Abbas Orabi, Kaushik Ramaiya, Sameer Al Shammari, Dina Shrestha, Khalid Shaikh, Sachitha Abhayaratna, PradeepK Shrestha, Aravinthan Mahalingam, Mazen Askheta, AlyAhmed A. Rahim, Fatimah Eliana, HariK Shrestha, Sandeep Chaudhary, Nancy Ngugi, JeanClaude Mbanya, ThanThan Aye, TintSwe Latt, ZhanayA Akanov, AbbasRaza Syed, Nikhil Tandon, AG Unnikrishnan, SV Madhu, Ali Jawa, Subhankar Chowdhury, Sarita Bajaj, AshokKumar Das. Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force. Indian Journal of Endocrinology and Metabolism 2018; 22(1) doi: 10.4103/ijem.IJEM_556_17
|
| 41 |
Lee-Ling Lim, Eric S. H. Lau, Siew Pheng Chan, Linong Ji, Soo Lim, Sirinart Sirinvaravong, A.G. Unnikrishnan, Andrea O. Y. Luk, Viviana Cortese, Alexandra Durocher, Juliana C. N. Chan. Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes Research and Clinical Practice 2023; 203 doi: 10.1016/j.diabres.2023.110855
|
| 42 |
Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund, Jan W Eriksson, Simon Heller, Ole Holm Hels, Richard Pratley, Thozhukat Sathyapalan, Cyrus Desouza, R Abramof, D Alpenidze, S Aronoff, K Astamirova, B Barker, G Bedel, L Belousova, M Benson, I Beshay, W Biggs, K Blaze, P Bogdanski, R Busch, S Chaidarun, S Chandran, A Chang, S Chilka, A Cleland, L Connery, G Cornett, B Delgado, C Desouza, T Donner, K Eliasson, J Eriksson, S Folkerth, K Forshaw, H A Frandsen, E Frolova, W Gandy, G Gatipon, A Golovach, L Gonzalez-Orozco, J Gumprecht, E Haddad, T K Hansen, T Hart, S Hasan, B Hella, S Heller, M Hellgren, M Hewitt, S Hietaniemi, M Hitz, P Houser, R Huntley, R Jackson, P E Jakobsen, A Kapoor, L Kargina, E Kazakova, K Khan, E Klein, H Knoble, N Krasnopeeva (Kabachkova), A Krzeminski, M Kunitsyna, J Lawhead, K Levin, P Levin, L Lewy-Alterbaum, S Lindmark, R Lindsay, A Luts, T Lysenko, S Madsbad, T Maxwell, C Mbogua, J Mcknight, K Metsärinne, T Milovanova, E Morawski, O Mosenzon, D Nabriski, H Nguyen, P Nicol, S Nieminen, A Nikkola, P Norwood, P O'Donnell, A Odugbesan, J Parker, Y Pergaeva, A Peskov, S Plevin, J Pouzar, R Pratley, J Reed, P Rossing, T Sathyapalan, M Sergeeva-Kondrachenko, Z Shaikh, M Shamkhalova, N Shehadeh, Y Shlesinger, R Silver, B Snyder, J Soufer, J Strand, S Sulosaari, A Tirosh, H Traylor, N Uhlenius, G Vagapova, M Yanovskaya, L Zarutskaya, E Zhdanova. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial. The Lancet Diabetes & Endocrinology 2019; 7(7) doi: 10.1016/S2213-8587(19)30192-5
|
| 43 |
Dhruvi Hasnani, Vipul Chavda, Dinesh Agrawal, Bijay Patni, Ashwin David, Sachin Gathe, Rajeev Chawla, Jothydev Kesavadev, Sunil Gupta, Shriji Hasnani, Banshi Saboo. Validation of RSSDI therapeutic wheel with clinical experience of Indian physicians. International Journal of Diabetes in Developing Countries 2022; 42(3) doi: 10.1007/s13410-021-00998-6
|
| 44 |
Anastasios Tentolouris, Ioanna Eleftheriadou, Evangelia Tzeravini, Kostas Athanasakis, Ioanna A. Anastasiou, John Kyriopoulos, Nikolaos Tentolouris. Management of diabetes mellitus and patients' attitude towards the disease: Data from a nationwide study in Greece. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2) doi: 10.1016/j.dsx.2019.01.030
|
| 45 |
Jinnie J. Rhee, Jialin Han, Maria E. Montez-Rath, Sun H. Kim, Mark R. Cullen, Randall S. Stafford, Wolfgang C. Winkelmayer, Glenn M. Chertow. Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. Journal of Diabetes and its Complications 2019; 33(11) doi: 10.1016/j.jdiacomp.2019.107423
|
| 46 |
Dimitrios Anyfantakis, Serafim Kastanakis. Hemiparesis and facial droop in an older woman. BMJ 2022; 376 doi: 10.1136/bmj-2021-067134
|
| 47 |
Tarek Atia, Mohammad Zahidul Iqbal, Hassan Fathy Ahmed, Hader I. Sakr, M. H. Abdelzaher, Deaa Fekri Morsi, Mostafa E. Metawee. Vitamin D Supplementation Could Enhance the Effectiveness of Glibenclamide in Treating Diabetes and Preventing Diabetic Nephropathy: A Biochemical, Histological and Immunohistochemical Study. Journal of Evidence-Based Integrative Medicine 2022; 27 doi: 10.1177/2515690X221116403
|
| 48 |
Sreenu Thupakula, Shiva Shankar Reddy Nimmala, Shauq Mumtaz Dawood, Raju Padiya. Synergistic anti-diabetic effect of phloroglucinol and total procyanidin dimer isolated from Vitis vinifera methanolic seed extract potentiates via suppressing oxidative stress: in-vitro evaluation studies. 3 Biotech 2024; 14(3) doi: 10.1007/s13205-024-03929-4
|
| 49 |
Sebastian Niezen, Humberto Diaz del Castillo, Lumen A. Mendez Castaner, Alessia Fornoni. Safety and efficacy of antihyperglycaemic agents in diabetic kidney disease. Endocrinology, Diabetes & Metabolism 2019; 2(3) doi: 10.1002/edm2.72
|
| 50 |
Sheng-Wei Pan, Yung-Feng Yen, Yu Ru Kou, Pei-Hung Chuang, Vincent Yi-Fong Su, Jia-Yih Feng, Yu-Jiun Chan, Wei-Juin Su. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment. Chest 2018; 153(6) doi: 10.1016/j.chest.2017.11.040
|
| 51 |
ARIFAH S. WAHYUNI, FIRDA AYU F. RAHMAWATI, DISKI W. WIJIANTO, RETNO A. UMNIYYAH. EFFECTIVENESS AND SAFETY OF USE OF BIGUANIDE AND SULFONYLUREA DRUGS WITH HISTOPATHOLOGICAL ANALYSIS AND PARAMETERS OF THE KIDNEY, LIVER AND PANCREAS IN ALLOXAN-INDUCED RATS. International Journal of Applied Pharmaceutics 2024; doi: 10.22159/ijap.2024v16s5.52469
|
| 52 |
Po-Chung Cheng, Shang-Ren Hsu, Jeng-Fu Kuo, Yun-Chung Cheng, Yu-Hsiu Liu, Shih-Te Tu. Comparing the Effect of Dipeptidyl-Peptidase 4 Inhibitors and Sulfonylureas on Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Prospective Open-Label Study. Journal of Clinical Medicine 2019; 8(10) doi: 10.3390/jcm8101715
|
| 53 |
Tadao Akizawa, Keiko Tanaka-Amino, Tetsuro Otsuka, Yusuke Yamaguchi. Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat. Clinical and Experimental Nephrology 2022; 26(9) doi: 10.1007/s10157-022-02225-w
|